In the final part of his conversation with Pharmaceutical Executive, Sandy Donaldson discusses the challenges that pharma faces when marketing direct-to-consumers.
Sandy Donaldson
Advertisement
Sandy Donaldson is a co-founder and chief strategy officer at Impiricus.
Articles by Sandy Donaldson
In the second part of his conversation with Pharmaceutical Executive, Sandy Donaldson discusses how pharma marketing teams decide who to target with advertising campaigns.
Sandy Donaldson discusses how pharma companies are developing precise marketing strategies for the modern world.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing
3
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5